pyrazines has been researched along with Rift Valley Fever in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Borrego, B; Brun, A; de la Losa, N; Moreno, S; Weber, F | 1 |
| Bailey, KW; Furuta, Y; Gowen, BB; Kumaki, Y; Scharton, D; Van Wettere, A; Vest, Z; Westover, JB | 1 |
| Bethel, LM; Caroline, AL; Hartman, AL; Oury, TD; Powell, DS; Reed, DS | 1 |
3 other study(ies) available for pyrazines and Rift Valley Fever
| Article | Year |
|---|---|
The Change P82L in the Rift Valley Fever Virus NSs Protein Confers Attenuation in Mice.
Topics: Amides; Amino Acid Substitution; Animals; Antiviral Agents; Cell Line; Chlorocebus aethiops; Cricetinae; HEK293 Cells; Humans; Kidney; Male; Mice; Mice, Inbred BALB C; Pyrazines; Reverse Genetics; Rift Valley Fever; Rift Valley fever virus; Vero Cells; Viral Nonstructural Proteins; Virulence; Virulence Factors | 2021 |
Favipiravir (T-705) protects against peracute Rift Valley fever virus infection and reduces delayed-onset neurologic disease observed with ribavirin treatment.
Topics: Amides; Animals; Antiviral Agents; Cell Line; Central Nervous System Viral Diseases; Cricetinae; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Microbial Sensitivity Tests; Pyrazines; Rift Valley Fever; Rift Valley fever virus; Viral Load | 2014 |
Broad spectrum antiviral activity of favipiravir (T-705): protection from highly lethal inhalational Rift Valley Fever.
Topics: Amides; Animals; Antiviral Agents; Chemoprevention; Female; Fever; Pyrazines; Rats; Rats, Inbred WF; Rift Valley Fever; Survival Analysis; Treatment Outcome; Weight Loss | 2014 |